Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study

BACKGROUND: There have been few real-life dose-comparing studies on the efficacy and safety of secukinumab in Chinese patients with plaque psoriasis. We conducted a real-life cohort study to investigate the efficacy and safety of secukinumab 150 and 300 mg in Chinese patients with moderate-to-severe...

Full description

Saved in:
Bibliographic Details
Published in:Chin Med J (Engl)
Main Authors: Zhao, Yan, Cai, Lin, Liu, Xiao-Yang, Zhang, Heng, Zhang, Jian-Zhong
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2021
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183798/
https://ncbi.nlm.nih.gov/pubmed/33950871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000001510
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items